Abstract (EN):
Fluidinova, a recent start-up high technology engineering company, has developed and is now commercializing a novel continuous industrial reactor NETmix for the manufacture of high added value products, such as nanomaterials, microemulsions, and pharmaceutical products. Through this technology, Fluidinova, in cooperation with Instituto de Engenharia Biomidica, has developed and patented the industrial process for the synthesis of a new high quality product consisting of hydroxyapatite nanoparticles with extremely high purity and crystallinity to be used as biocompatible nanomaterial for biomedical and pharmaceutical applications, to improve the quality of the already existing hydroxyapatite based medical devices, such as bone grafts, coated implants, and drug delivery systems.
Language:
English
Type (Professor's evaluation):
Scientific
No. of pages:
6